Skip to main content

Co-Diagnostics, Inc.

CODX
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001692415

No open-market purchases or sales by Co-Diagnostics, Inc. insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $1.85M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Co-Diagnostics, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of CODX: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders7166−5
Shares7.23M6.21M−1.02M (−14.1%)
Value$40.9M$20.0M−$21.0M (−51.3%)

New holders (13)

Institutions that held Co-Diagnostics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to CODX in Q3 2022
InstitutionSharesValue% of portfolio
Walleye Capital LLC137,389$441.0K0.01%
TownSquare Capital, LLC67,226$216.0K0.01%
Cambridge Investment Research Advisors, Inc.65,016$209.0K0.00%
Engineers Gate Manager LP50,593$162.0K0.01%
Tower Research Capital LLC (TRC)28,863$93.0K0.00%
Jane Street Group, LLC27,852$89.0K0.00%
Simplex Trading, LLC16,539$53.0K0.00%
Two Sigma Securities, LLC15,350$49.0K0.01%
UBS Group AG8,491$27.0K0.00%
Aquatic Capital Management LLC2,200$7.00K0.00%
Parallax Volatility Advisers, L.P.207$1.00K0.00%
Axiom Investment Management LLC20$00.00%
Bogart Wealth, LLC100$00.00%

Sold out (18)

Institutions that held Co-Diagnostics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.